ArticleCellular oncology (Dordrecht, Netherlands)2024

GALNT6 drives lenvatinib resistance in hepatocellular carcinoma through autophagy and cancer-associated fibroblast activation.

Peiling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.